QQQ   431.84 (+0.18%)
AAPL   169.45 (-1.88%)
MSFT   416.65 (+0.73%)
META   503.35 (+0.62%)
GOOGL   154.80 (-0.04%)
AMZN   184.20 (+0.32%)
TSLA   157.26 (-2.61%)
NVDA   871.13 (+1.29%)
AMD   163.01 (+1.68%)
NIO   3.82 (-1.80%)
BABA   69.64 (-1.39%)
T   16.06 (-1.11%)
F   12.14 (-0.74%)
MU   120.98 (-0.32%)
GE   155.43 (+1.13%)
CGC   7.03 (+0.72%)
DIS   114.24 (+1.14%)
AMC   2.73 (+10.53%)
PFE   25.85 (-0.23%)
PYPL   64.09 (+0.91%)
XOM   118.78 (-0.75%)
QQQ   431.84 (+0.18%)
AAPL   169.45 (-1.88%)
MSFT   416.65 (+0.73%)
META   503.35 (+0.62%)
GOOGL   154.80 (-0.04%)
AMZN   184.20 (+0.32%)
TSLA   157.26 (-2.61%)
NVDA   871.13 (+1.29%)
AMD   163.01 (+1.68%)
NIO   3.82 (-1.80%)
BABA   69.64 (-1.39%)
T   16.06 (-1.11%)
F   12.14 (-0.74%)
MU   120.98 (-0.32%)
GE   155.43 (+1.13%)
CGC   7.03 (+0.72%)
DIS   114.24 (+1.14%)
AMC   2.73 (+10.53%)
PFE   25.85 (-0.23%)
PYPL   64.09 (+0.91%)
XOM   118.78 (-0.75%)
QQQ   431.84 (+0.18%)
AAPL   169.45 (-1.88%)
MSFT   416.65 (+0.73%)
META   503.35 (+0.62%)
GOOGL   154.80 (-0.04%)
AMZN   184.20 (+0.32%)
TSLA   157.26 (-2.61%)
NVDA   871.13 (+1.29%)
AMD   163.01 (+1.68%)
NIO   3.82 (-1.80%)
BABA   69.64 (-1.39%)
T   16.06 (-1.11%)
F   12.14 (-0.74%)
MU   120.98 (-0.32%)
GE   155.43 (+1.13%)
CGC   7.03 (+0.72%)
DIS   114.24 (+1.14%)
AMC   2.73 (+10.53%)
PFE   25.85 (-0.23%)
PYPL   64.09 (+0.91%)
XOM   118.78 (-0.75%)
QQQ   431.84 (+0.18%)
AAPL   169.45 (-1.88%)
MSFT   416.65 (+0.73%)
META   503.35 (+0.62%)
GOOGL   154.80 (-0.04%)
AMZN   184.20 (+0.32%)
TSLA   157.26 (-2.61%)
NVDA   871.13 (+1.29%)
AMD   163.01 (+1.68%)
NIO   3.82 (-1.80%)
BABA   69.64 (-1.39%)
T   16.06 (-1.11%)
F   12.14 (-0.74%)
MU   120.98 (-0.32%)
GE   155.43 (+1.13%)
CGC   7.03 (+0.72%)
DIS   114.24 (+1.14%)
AMC   2.73 (+10.53%)
PFE   25.85 (-0.23%)
PYPL   64.09 (+0.91%)
XOM   118.78 (-0.75%)
NASDAQ:PDEX

Pro-Dex (PDEX) Stock Price, News & Analysis

$18.49
-0.48 (-2.53%)
(As of 12:10 PM ET)
Today's Range
$18.25
$18.49
50-Day Range
$16.50
$21.11
52-Week Range
$14.51
$22.99
Volume
614 shs
Average Volume
8,092 shs
Market Capitalization
$64.90 million
P/E Ratio
24.65
Dividend Yield
N/A
Price Target
N/A
PDEX stock logo

About Pro-Dex Stock (NASDAQ:PDEX)

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

PDEX Stock Price History

PDEX Stock News Headlines

Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
Monogram Orthopaedics reports FY results
Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
Pro-Dex Inc PDEX
Pro-Dex, Inc. Announces Fiscal 2024 First Quarter Results
North American Morning Briefing: S&P 500 Futures -2-
Pro-Dex's (NASDAQ:PDEX) Returns Have Hit A Wall
PDEX Pro-Dex, Inc.
See More Headlines
Receive PDEX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/08/2024
Today
4/16/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:PDEX
Employees
145
Year Founded
N/A

Profitability

Net Income
$7.07 million
Pretax Margin
8.28%

Debt

Sales & Book Value

Annual Sales
$48.24 million
Cash Flow
$2.36 per share
Book Value
$8.91 per share

Miscellaneous

Free Float
2,015,000
Market Cap
$66.60 million
Optionable
Not Optionable
Beta
0.60
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

PDEX Stock Analysis - Frequently Asked Questions

How have PDEX shares performed in 2024?

Pro-Dex's stock was trading at $17.52 at the start of the year. Since then, PDEX stock has increased by 8.3% and is now trading at $18.9680.
View the best growth stocks for 2024 here
.

Are investors shorting Pro-Dex?

Pro-Dex saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 14,800 shares, a decrease of 20.4% from the March 15th total of 18,600 shares. Based on an average daily trading volume, of 8,500 shares, the days-to-cover ratio is currently 1.7 days. Currently, 0.6% of the company's stock are sold short.
View Pro-Dex's Short Interest
.

When is Pro-Dex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our PDEX earnings forecast
.

How were Pro-Dex's earnings last quarter?

Pro-Dex, Inc. (NASDAQ:PDEX) announced its earnings results on Thursday, February, 8th. The medical instruments supplier reported $0.14 earnings per share for the quarter. The medical instruments supplier earned $12.59 million during the quarter. Pro-Dex had a trailing twelve-month return on equity of 8.97% and a net margin of 5.59%.

What is Michael J. Berthelot's approval rating as Pro-Dex's CEO?

3 employees have rated Pro-Dex Chief Executive Officer Michael J. Berthelot on Glassdoor.com. Michael J. Berthelot has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Pro-Dex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pro-Dex investors own include KEMET (KEM), NVIDIA (NVDA), Enterprise Products Partners (EPD), Micron Technology (MU), AT&T (T), AbbVie (ABBV), Alibaba Group (BABA), Bank of America (BAC), Marvell Technology (MRVL) and UnitedHealth Group (UNH).

How do I buy shares of Pro-Dex?

Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PDEX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners